The 10th anniversary of The Lancet Respiratory Medicine is an appropriate time to
acknowledge advances in the management of interstitial lung disease (ILD) and to …

The spectrum of fibrotic interstitial lung disease (ILD) encompasses dozens of
heterogeneous disorders of multiple causes that are characterised by the predominant …

Over 200 interstitial lung diseases, from ultra rare to relatively common, are recognised.
Most interstitial lung diseases are characterised by inflammation or fibrosis within the …

Idiopathic pulmonary fibrosis (IPF) is a chronic fibrotic lung disorder of unknown cause that
is fatal within 3· 0–3· 5 years irrespective of treatment. 1 In 2013, an update of the …

Pulmonary fibrosis encompasses a wide range of fibrosing interstitial lung diseases (ILDs)
with different underlying causes. In the past two decades, most focus has been on idiopathic …

The excellent Review of systemic sclerosis-associated interstitial lung disease (SSc-ILD) by
Apostolos Perelas and colleagues1 in this issue is testament to the large body of work over …

Entomologically, metamorphosis is defined as the process of transformation from an
immature form to an adult form. No better term exists for the coming of age of interstitial lung …

Comment 126 www. thelancet. com/respiratory Vol 11 February 2023 therefore be
amenable to similar treatment strategies. 1, 2 This evidence points to the existence of …

The year 2014 was a landmark one, with true breakthroughs in our knowledge of the
interstitial lung diseases (ILDs), most notably for idiopathic pulmonary fibrosis (IPF), with the …

Interstitial lung diseases (ILDs) are typically classified on the basis of their underlying
causes; however, most ILDs can present with a multitude of morphological patterns on chest …